ロード中...
Nicotinic receptors as CNS targets for Parkinson’s disease
Parkinson’s disease is a debilitating neurodegenerative movement disorder characterized by damage to the nigrostriatal dopaminergic system. Current therapies are symptomatic only and may be accompanied by serious side effects. There is therefore a continual search for novel compounds for the treatme...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2046219/ https://ncbi.nlm.nih.gov/pubmed/17631864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2007.06.015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|